While it’s basketball season, football keeps making headlines, especially at the college level, so this week’s edition of Random Thoughts centers around the college game, plus a bit of high school, ...

RTX's Raytheon has secured a $1.7 billion contract to supply Spain with four Patriot air and missile defense systems. The aerospace and defense company said Tuesday that under the terms of the foreign ...

(NEXSTAR) — The Powerball jackpot continues to grow after no one won the big prize in Monday night’s drawing. The prize now stands at $1.7 billion (cash option $781.3 Million). The winning numbers ...

The Powerball winning numbers are in for the Monday, Dec. 22 drawing for the fourth-largest Powerball jackpot in the history of the multistate lottery. After no one hit the winning numbers on Monday, ...

There was no winner in Monday's drawing. The Powerball jackpot has soared to one of the largest in the lottery game's history. The current jackpot is estimated to be $1.7 billion for the drawing on ...

DECATUR, Ill. (WAND) - Someone who bought a Powerball ticket in Illinois has an extra million bucks this holiday season. It's not immediately clear where the ticket was purchased or who won. Powerball ...

The Powerball jackpot climbed to an estimated $1.7 billion, the fourth-largest in the game’s history, after no ticket matched all six winning numbers in Monday night’s drawing. The cash option is now ...

As families gather for the holidays, millions of Powerball players are also gathering hope eyeing one of the largest jackpots the game has ever seen. The lucky lottery player who finally claims the ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Deadline’s Read the Screenplay series spotlighting the scripts behind the awards season’s most talked-about movies continues with Apple Original Films and Warner Bros‘ F1, directed by Joseph Kosinski ...

Sanofi bought Dren’s DR-0201 program earlier this year for $600 million upfront and is running two Phase I trials in undisclosed inflammatory indications. After buying Dren Bio’s B cell depletion ...